Form D · Venture Capital Fund
Romix Biosciences SPV a Series of CGF2021 LLC
Claymont, DE · CIK 0002104481
Offering snapshot reported Jan 27, 2026 · SEC filing
- Reported sold
- $175K Offering amount: $175K
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 26, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 27, 2026 | Initial | $175,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-571300
Source: Form D, filed Jan 27, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brett Sagan | Executive |
| Llc Sydecar | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
2093 Philadelphia Pike 5885
Claymont, DE, 19703
Claymont, DE, 19703